CEL-SCI’s Chief Scientific Officer Discusses Cancer Immunotherapy Multikine

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 8/19/2026

1. MRNA
2. KLAR
3. KEYS
4. PANW
5. HD
6. SPY
7. MRK
8. DVLT
9. MRCY
10. LOW

Go back to CEL-SCI’s Chief Scientific Officer Discusses Cancer Immunotherapy Multikine
CEL-SCI CORPORATION (NYSE: CVM) Delayed: 1.64 +0.05 (3.14%)
Previous Close $1.59    52 Week High $0.66 
Open $1.61    52 Week Low $0.20 
Day High $1.69    P/E N/A 
Day Low $1.59    EPS $-0.34 
Volume 184,685       

CEL-SCI CORPORATION (NYSE: CVM) Delayed: 1.64 +0.05 (3.14%)
Previous Close $1.59    52 Week High $0.66 
Open $1.61    52 Week Low $0.20 
Day High $1.69    P/E N/A 
Day Low $1.59    EPS $-0.34 
Volume 184,685